Likewise, Huang and colleagues, presented evidence that identifying the therapeutic targets for AKT/PI3K/mTOR axis regulation may provide interesting options for obesity treatment [42]. Here, AKT1 is linked to obesity due to melanocortin 4 receptor deficiency.